TY  - RPRT
TI  - Asymmetric assessments in valuing pharmaceutical risks.
AU  - W K Viscusi
AU  - W A Magat
AU  - R Scharff
PY  - 1996
UR  - https://pubmed.ncbi.nlm.nih.gov/8969313/
ID  - 8969313
ER  -